Intech Biopharm (Taiwan) Probability of Future Stock Price Finishing Over 32.13

6461 Stock  TWD 25.85  0.05  0.19%   
Intech Biopharm's future price is the expected price of Intech Biopharm instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Intech Biopharm performance during a given time horizon utilizing its historical volatility. Check out Intech Biopharm Backtesting, Intech Biopharm Valuation, Intech Biopharm Correlation, Intech Biopharm Hype Analysis, Intech Biopharm Volatility, Intech Biopharm History as well as Intech Biopharm Performance.
  
Please specify Intech Biopharm's target price for which you would like Intech Biopharm odds to be computed.

Intech Biopharm Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intech Biopharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intech Biopharm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Intech Biopharm generated a negative expected return over the last 90 days
Intech Biopharm has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 38.9 M. Net Loss for the year was (301.76 M) with loss before overhead, payroll, taxes, and interest of (119.37 M).
Intech Biopharm generates negative cash flow from operations
About 47.0% of the company shares are owned by insiders or employees

Intech Biopharm Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intech Stock often depends not only on the future outlook of the current and potential Intech Biopharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intech Biopharm's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding116.3 M

Intech Biopharm Technical Analysis

Intech Biopharm's future price can be derived by breaking down and analyzing its technical indicators over time. Intech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intech Biopharm. In general, you should focus on analyzing Intech Stock price patterns and their correlations with different microeconomic environments and drivers.

Intech Biopharm Predictive Forecast Models

Intech Biopharm's time-series forecasting models is one of many Intech Biopharm's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intech Biopharm's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Intech Biopharm

Checking the ongoing alerts about Intech Biopharm for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intech Biopharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Intech Biopharm generated a negative expected return over the last 90 days
Intech Biopharm has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 38.9 M. Net Loss for the year was (301.76 M) with loss before overhead, payroll, taxes, and interest of (119.37 M).
Intech Biopharm generates negative cash flow from operations
About 47.0% of the company shares are owned by insiders or employees

Additional Tools for Intech Stock Analysis

When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.